Michael R. Bishop to Molecular Sequence Data
This is a "connection" page, showing publications Michael R. Bishop has written about Molecular Sequence Data.
Connection Strength
0.030
-
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J Clin Oncol. 1996 Apr; 14(4):1320-6.
Score: 0.025
-
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial. Antisense Res Dev. 1993; 3(4):383-90.
Score: 0.005